E2/E3 and E3/E4 Genotypes of the Apolipoprotein E are Associated with Higher Risk of Diabetes Mellitus in Patients with Hypertension

References

• Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep. 2013;15(3):134–136. doi:10.1007/s11906-013-0340-9
   PubMed Web of Science ®Google Scholar
• Pickering GW. The natural history of hypertension. Br Med Bull. 1952;8(4):305–309. doi:10.1093/oxfordjournals.bmb.a074193
   PubMed Web of Science ®Google Scholar
• Yin R, Yin L, Li L, et al. Hypertension in China: burdens, guidelines and policy responses: a state-of-The-art review. J Hum Hypertens. 2022;36(2):126–134. doi:10.1038/s41371-021-00570-z
   PubMed Web of Science ®Google Scholar
• Hedner T, Kjeldsen SE, Narkiewicz K. State of global health--hypertension burden and control. Blood Press. 2012;21 Suppl 1(sup1):1–2. doi:10.3109/08037051.2012.704786
   PubMedGoogle Scholar
• Liu S, Yuan H, Jiang C, Xu J, Qiu X, Luo J. The blood pressure control and arteriosclerotic cardiovascular risk among Chinese community hypertensive patients. Sci Rep. 2021;11(1):19066. doi:10.1038/s41598-021-98745-8
   PubMed Web of Science ®Google Scholar
• Gregg EW, Buckley J, Ali MK, et al. Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact. Lancet. 2023;401(10384):1302–1312. doi:10.1016/S0140-6736(23)00001-6
   PubMed Web of Science ®Google Scholar
• Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: the Women’s Health Study. Eur Heart J. 2007;28(23):2937–2943. doi:10.1093/eurheartj/ehm400
   PubMed Web of Science ®Google Scholar
• Moreno B, de Faria AP, Ritter AMV, et al. Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus. J Clin Hypertens. 2018;20(5):910–917. doi:10.1111/jch.13293
   Web of Science ®Google Scholar
• Wang J, Ma JJ, Liu J, Zeng DD, Song C, Cao Z. Prevalence and risk factors of comorbidities among hypertensive patients in China. Int J Med Sci. 2017;14(3):201–212. doi:10.7150/ijms.16974
   PubMed Web of Science ®Google Scholar
• Singh PP, Singh M, Mastana SS. APOE distribution in world populations with new data from India and the UK. Ann Hum Biol. 2006;33(3):279–308. doi:10.1080/03014460600594513
   PubMed Web of Science ®Google Scholar
• Alidu H, Dapare PPM, Quaye L. Insulin resistance in relation to hypertension and dyslipidaemia among men clinically diagnosed with type 2 diabetes. Biomed Res Int. 2023;2023:8873226. doi:10.1155/2023/8873226
   PubMed Web of Science ®Google Scholar
• Marais AD. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. Pathology. 2019;51(2):165–176. doi:10.1016/j.pathol.2018.11.002
   PubMed Web of Science ®Google Scholar
• Khalil YA, Rabès JP, Boileau C, Varret M. APOE gene variants in primary dyslipidemia. Atherosclerosis. 2021;328:11–22. doi:10.1016/j.atherosclerosis.2021.05.007
   PubMed Web of Science ®Google Scholar
• Seripa D, D’Onofrio G, Panza F, Cascavilla L, Masullo C, Pilotto A. The genetics of the human APOE polymorphism. Rejuvenation Res. 2011;14(5):491–500. doi:10.1089/rej.2011.1169
   PubMed Web of Science ®Google Scholar
• Rao H, Wu H, Yu Z, Huang Q. APOE genetic polymorphism rs7412 T/T genotype may be a risk factor for essential hypertension among Hakka People in Southern China. Int J Hypertens. 2022;2022:8145896. doi:10.1155/2022/8145896
   PubMed Web of Science ®Google Scholar
• Zeng Y, Wen S, Huan L, Xiong L, Zhong B, Wang P. Association of ApoE gene polymorphisms with serum lipid levels and the risk of type 2 diabetes mellitus in the Chinese Han population of central China. PeerJ. 2023;11:e15226. doi:10.7717/peerj.15226
   PubMed Web of Science ®Google Scholar
• Niu W, Qi Y, Qian Y, Gao P, Zhu D. The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens Res. 2009;32(12):1060–1066. doi:10.1038/hr.2009.164
   PubMed Web of Science ®Google Scholar
• Niu WQ, Qi Y. Meta-based evidence for apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphism in association with hypertension among Chinese. J Hum Hypertens. 2011;25(12):725–731. doi:10.1038/jhh.2010.116
   PubMed Web of Science ®Google Scholar
• Shi J, Liu Y, Liu Y, et al. Association between ApoE polymorphism and hypertension: a meta-analysis of 28 studies including 5898 cases and 7518 controls. Gene. 2018;675:197–207. doi:10.1016/j.gene.2018.06.097
   PubMed Web of Science ®Google Scholar
• Chen DW, Shi JK, Li Y, Yang Y, Ren SP. Association between ApoE polymorphism and type 2 diabetes: a meta-analysis of 59 studies. Biomed Environ Sci. 2019;32(11):823–838. doi:10.3967/bes2019.104
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen Z, Zhang L, et al. Status of hypertension in china: results from the China Hypertension Survey, 2012–2015. Circulation. 2018;137(22):2344–2356. doi:10.1161/CIRCULATIONAHA.117.032380
   PubMed Web of Science ®Google Scholar
• Benhalima K, Van Crombrugge P, Moyson C, et al. Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria. Eur J Endocrinol. 2019;180(6):353–363. doi:10.1530/EJE-19-0117
   PubMed Web of Science ®Google Scholar
• Liu Q, Wu H, Yu Z, Huang Q, Zhong Z. APOE gene ɛ4 allele (388C-526C) effects on serum lipids and risk of coronary artery disease in southern Chinese Hakka population. J Clin Lab Anal. 2021;35(9):e23925. doi:10.1002/jcla.23925
   PubMed Web of Science ®Google Scholar
• Selby JV, Peng T, Karter AJ, et al. High rates of co-occurrence of hypertension, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population. Am J Manag Care. 2004;10(2 Pt 2):163–170. PMID: 15005509.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Lim NK, Choi SJ, Park HY. Hypertension is an independent risk factor for type 2 diabetes: the Korean genome and epidemiology study. Hypertens Res. 2015;38(11):783–789. doi:10.1038/hr.2015.72
   PubMed Web of Science ®Google Scholar
• Jia G, Sowers JR. Hypertension in diabetes: an update of basic mechanisms and clinical disease. Hypertension. 2021;78(5):1197–1205. doi:10.1161/HYPERTENSIONAHA.121.17981
   PubMed Web of Science ®Google Scholar
• Deng H, Hu P, Li H, et al. Novel lipid indicators and the risk of type 2 diabetes mellitus among Chinese hypertensive patients: findings from the Guangzhou Heart Study. Cardiovasc Diabetol. 2022;21(1):212. doi:10.1186/s12933-022-01660-z
   PubMed Web of Science ®Google Scholar
• Chen Y, Ma J, Lu D, Fang Y. The risk factors of type 2 diabetes in hypertensive subjects. Front Endocrinol. 2022;13:901614. doi:10.3389/fendo.2022.901614
   PubMed Web of Science ®Google Scholar
• Ariyanti R, Besral B. Dyslipidemia associated with hypertension increases the risks for coronary heart disease: a case-control study in Harapan Kita Hospital, National Cardiovascular Center, Jakarta. J Lipids. 2019;2019:2517013. doi:10.1155/2019/2517013
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Reboldi G, Angeli F, et al. Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease. Hypertension. 2015;65(1):108–114. doi:10.1161/HYPERTENSIONAHA.114.04310
   PubMed Web of Science ®Google Scholar
• Kane JP, Pullinger CR, Goldfine ID, Malloy MJ. Dyslipidemia and diabetes mellitus: role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus. Curr Opin Pharmacol. 2021;61:21–27. doi:10.1016/j.coph.2021.08.013
   PubMed Web of Science ®Google Scholar
• Domingo-Espín J, Nilsson O, Bernfur K, Del Giudice R, Lagerstedt JO. Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism. Biochim Biophys Acta Mol Basis Dis. 2018;1864(9 Pt B):2822–2834. doi:10.1016/j.bbadis.2018.05.014
   PubMed Web of Science ®Google Scholar
• Malyala R, Rapi L, Nash MM, Prasad GVR. Serum apolipoprotein B and A1 concentrations predict late-onset posttransplant diabetes mellitus in prevalent adult kidney transplant recipients. Can J Kidney Health Dis. 2019;6:2054358119850536. doi:10.1177/2054358119850536
   Google Scholar
• Baszczuk A, Musialik K, Kopczyński J, et al. Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension. Adv Med Sci. 2014;59(1):68–73. doi:10.1016/j.advms.2013.08.001
   PubMed Web of Science ®Google Scholar
• Seo JY, Youn BJ, Cheong HS, Shin HD. Association of APOE genotype with lipid profiles and type 2 diabetes mellitus in a Korean population. Genes Genomics. 2021;43(7):725–735. doi:10.1007/s13258-021-01095-y
   PubMed Web of Science ®Google Scholar
• Liu L, Shen G, Huang JY, et al. U-shaped association between low-density lipid cholesterol and diabetes mellitus in patients with hypertension. Lipids Health Dis. 2019;18(1):163. doi:10.1186/s12944-019-1105-5
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang Y, Zhao H, et al. Dissecting the association of apolipoprotein e gene polymorphisms with type 2 diabetes mellitus and coronary artery disease. Front Endocrinol. 2022;13:838547. doi:10.3389/fendo.2022.838547
   PubMed Web of Science ®Google Scholar
• Gao C, Fu X, Chu Q, Li J, Shu G. Relationship between the apoe gene polymorphism and type 2 diabetes mellitus complications. Genet Test Mol Biomarkers. 2021;25(2):111–115. doi:10.1089/gtmb.2020.0130
   PubMed Web of Science ®Google Scholar
• Srirojnopkun C, Kietrungwilaikul K, Boonsong K, Thongpoonkaew J, Jeenduang N. Association of APOE and CETP TaqIB polymorphisms with type 2 diabetes mellitus. Arch Med Res. 2018;49(7):479–485. doi:10.1016/j.arcmed.2019.02.005
   PubMed Web of Science ®Google Scholar
• Pitchika A, Markus MRP, Schipf S, et al. Longitudinal association of Apolipoprotein E polymorphism with lipid profile, type 2 diabetes and metabolic syndrome: results from a 15 year follow-up study. Diabetes Res Clin Pract. 2022;185:109778. doi:10.1016/j.diabres.2022.109778
   PubMed Web of Science ®Google Scholar
• Galal AA, Abd Elmajeed AA, Elbaz RA, Wafa AM, Elshazli RM. Association of Apolipoprotein E gene polymorphism with the risk of T2DM and obesity among Egyptian subjects. Gene. 2021;769:145223. doi:10.1016/j.gene.2020.145223
   PubMed Web of Science ®Google Scholar
• Santos-Ferreira C, Baptista R, Oliveira-Santos M, Costa R, Pereira Moura J, Gonçalves L. Apolipoprotein E2 genotype is associated with a 2-fold increase in the incidence of type 2 diabetes mellitus: results from a long-term observational study. J Lipids. 2019;2019:1698610. doi:10.1155/2019/1698610
   PubMed Web of Science ®Google Scholar
• Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–584. doi:10.1016/j.cjca.2017.12.005
   PubMed Web of Science ®Google Scholar
• Yousef H, Khandoker AH, Feng SF, Helf C, Jelinek HF. Inflammation, oxidative stress and mitochondrial dysfunction in the progression of type II diabetes mellitus with coexisting hypertension. Front Endocrinol. 2023;14:1173402. doi:10.3389/fendo.2023.1173402
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet L, Pagler T, Gautier EL, et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science. 2010;328(5986):1689–1693. doi:10.1126/science.1189731
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Akhtari M, Tolani S, et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest. 2011;121(10):4138–4149. doi:10.1172/JCI57559
   PubMed Web of Science ®Google Scholar
• Koren-Iton A, Salomon-Zimri S, Smolar A, Shavit-Stein E. Central and peripheral mechanisms in ApoE4-driven diabetic pathology. Int J Mol Sci. 2020;21(4):1289. doi:10.3390/ijms21041289
   PubMed Web of Science ®Google Scholar
• Shi LJ, Tang X, He J, Shi W. Genetic evidence for a causal relationship between hyperlipidemia and type 2 diabetes in mice. Int J Mol Sci. 2022;23(11):6184. doi:10.3390/ijms23116184
   PubMed Web of Science ®Google Scholar